Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Authors
Keywords
-
Journal
Translational Neurodegeneration
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-04
DOI
10.1186/s40035-020-00187-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
- (2019) Alison Cave et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine
- (2018) Margherita Fabbri et al. MOVEMENT DISORDERS
- Evidence for Health Decision Making — Beyond Randomized, Controlled Trials
- (2017) Thomas R. Frieden NEW ENGLAND JOURNAL OF MEDICINE
- Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Andrew J. Lees et al. JAMA Neurology
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
- (2016) Joaquim J Ferreira et al. LANCET NEUROLOGY
- The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
- (2014) R. Cilia et al. BRAIN
- Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations
- (2014) José-Francisco Rocha et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Medicinal Chemistry of Catechol O-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility
- (2014) László E. Kiss et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries
- (2014) Marlene C. Hechtner et al. PARKINSONISM & RELATED DISORDERS
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications
- (2013) A. Storch et al. NEUROLOGY
- Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease
- (2012) J. J. Ferreira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials
- (2011) Spyridon Spyros Papapetropoulos CNS Neuroscience & Therapeutics
- Determination of minimal clinically important change in early and advanced Parkinson's disease
- (2011) Robert A. Hauser et al. MOVEMENT DISORDERS
- The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial
- (2010) Jean-Christophe Corvol et al. ANNALS OF NEUROLOGY
- The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale
- (2010) Lisa M. Shulman et al. ARCHIVES OF NEUROLOGY
- When Do Levodopa Motor Fluctuations First Appear in Parkinson’s Disease
- (2010) Fabrizio Stocchi et al. EUROPEAN NEUROLOGY
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More